The C-terminus region of β-arrestin1 modulates VE-cadherin expression and endothelial cell permeability

Cell Communication and Signaling

Volumn 11, Issue 1, 2013, Pages

  Hebda, Jagoda K ^a,b,c   Leclair, Héloïse M ^a,b,c   Azzi, Sandy ^a,b,c   Roussel, Célestin ^a,b,c,d   Scott, Mark G H ^a,b,c   Bidère, Nicolas ^e,f,g   Gavard, Julie ^a,b,c  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e HÔPITAL PAUL BROUSSE   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g Equipe Labellisée Ligue Nationale Contre le Cancer   (France)

Author keywords

arrestin; Endocytosis; Permeability; VE cadherin promoter; VEGF

Indexed keywords

AMINO ACID; BETA ARRESTIN 1; CLATHRIN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE PERMEABILITY; CELL VACUOLE; CONTROLLED STUDY; ENDOCYTOSIS; GENE ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTERNALIZATION; MEMBRANE DAMAGE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84878257391     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-11-37     Document Type: Article

References (24)

1. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Vestweber D, Winderlich M, Cagna G, Nottebaum AF, Trends Cell Biol 2009 19 1 8 15 10.1016/j.tcb.2008.10.001 19010680
2. Breaking the VE-cadherin bonds. Gavard J, FEBS Lett 2009 583 1 1 6 10.1016/j.febslet.2008.11.032 19059243
3. Endothelial cell-cell junctions: happy together. Dejana E, Nat Rev Mol Cell Biol 2004 5 4 261 270 10.1038/nrm1357 15071551
4. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oostuyse B, Dewerchin M, et al. Cell 1999 98 2 147 157 10.1016/S0092- 8674(00)81010-7 10428027
5. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus M, Lampugnani MG, Martin-Padura I, Stoppacciaro A, Ruco L, et al. Proc Natl Acad Sci USA 1999 96 17 9815 9820 10.1073/pnas.96.17.9815 10449777
6. VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Crosby CV, Fleming PA, Argraves WS, Corada M, Zanetta L, Dejana E, Drake CJ, Blood 2005 105 7 2771 2776 10.1182/blood-2004-06-2244 15604224
7. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Vittet D, Buchou T, Schweitzer A, Dejana E, Huber P, Proc Natl Acad Sci USA 1997 94 12 6273 6278 10.1073/pnas.94.12.6273 9177207
8. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. Esser S, Lampugnani MG, Corada M, Dejana E, Risau W, J Cell Sci 1998 111 Pt 13 1853 1865 9625748
9. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Gavard J, Gutkind JS, Nat Cell Biol 2006 8 11 1223 1234 10.1038/ncb1486 17060906
10. A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Gavard J, Hou X, Qu Y, Masedunskas A, Martin D, Weigert R, Li X, Gutkind JS, Mol Cell Biol 2009 29 9 2469 2480 10.1128/MCB.01304-08 19255141
11. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. Weis S, Cui J, Barnes L, Cheresh D, J Cell Biol 2004 167 2 223 229 10.1083/jcb.200408130 15504909
12. Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation. Le Guelte A, Galan-Moya EM, Dwyer J, Treps L, Kettler G, Hebda JK, Dubois S, Auffray C, Chneiweiss H, Bidere N, et al. J Cell Sci 2012 125 Pt 17 4137 4146 22685328
13. Inflammatory mediators induce sequestration of VE-cadherin in cultured human endothelial cells. Alexander JS, Alexander BC, Eppihimer LA, Goodyear N, Haque R, Davis CP, Kalogeris TJ, Carden DL, Zhu YN, Kevil CG, Inflammation 2000 24 2 99 113 10.1023/A:1007025325451 10718113
14. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Orsenigo F, Giampietro C, Ferrari A, Corada M, Galaup A, Sigismund S, Ristagno G, Maddaluno L, Young Koh G, Franco D, et al. Nat Commun 2012 3 1208 23169049
15. The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Gaengel K, Niaudet C, Hagikura K, Siemsen BL, Muhl L, Hofmann JJ, Ebarasi L, Nystrom S, Rymo S, Chen LL, et al. Dev Cell 2012 23 3 587 599 10.1016/j.devcel.2012.08.005 22975327
16. p120-catenin binding masks an endocytic signal conserved in classical cadherins. Nanes BA, Chiasson-MacKenzie C, Lowery AM, Ishiyama N, Faundez V, Ikura M, Vincent PA, Kowalczyk AP, J Cell Biol 2012 199 2 365 380 10.1083/jcb.201205029 23071156
17. p120-catenin inhibits VE-cadherin internalization through a Rho-independent mechanism. Chiasson CM, Wittich KB, Vincent PA, Faundez V, Kowalczyk AP, Mol Biol Cell 2009 20 7 1970 1980 10.1091/mbc.E08-07-0735 19211843
18. Cellular levels of p120 catenin function as a set point for cadherin expression levels in microvascular endothelial cells. Xiao K, Allison DF, Buckley KM, Kottke MD, Vincent PA, Faundez V, Kowalczyk AP, J Cell Biol 2003 163 3 535 545 10.1083/jcb.200306001 14610056
19. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Gavard J, Patel V, Gutkind JS, Dev Cell 2008 14 1 25 36 10.1016/j.devcel.2007.10.019 18194650
20. The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis. Prandini MH, Dreher I, Bouillot S, Benkerri S, Moll T, Huber P, Oncogene 2005 24 18 2992 3001 10.1038/sj.onc. 1208483 15735710
21. Beta-arrestins and cell signaling. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK, Annu Rev Physiol 2007 69 483 510 10.1146/annurev.physiol.69.022405.154749 17305471
22. Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2. Scott MG, Le Rouzic E, Perianin A, Pierotti V, Enslen H, Benichou S, Marullo S, Benmerah A, J Biol Chem 2002 277 40 37693 37701 10.1074/jbc.M207552200 12167659
23. The active conformation of beta-arrestin1: direct evidence for the phosphate sensor in the N-domain and conformational differences in the active states of beta-arrestins1 and -2. Nobles KN, Guan Z, Xiao K, Oas TG, Lefkowitz RJ, J Biol Chem 2007 282 29 21370 21381 10.1074/jbc.M611483200 17513300
24. Structure of active beta-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Shukla AK, Manglik A, Kruse AC, Xiao K, Reis RI, Tseng WC, Staus DP, Hilger D, Uysal S, Huang LY, et al. Nature 2013 497 7447 137 141 10.1038/nature12120 23604254